Brain metastases following interleukin-2 plus interferon-alpha-2a therapy: a follow-up study in 94 stage IV melanoma patients

This publication has 13 references indexed in Scilit:

• Whole brain irradiation for patients with metastatic melanoma: A review of 87 cases
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
  Journal of Clinical Oncology, 2000
• High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993
  Journal of Clinical Oncology, 1999
• Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b
  Journal of Clinical Oncology, 1999
• Induction of tyrosinase‐reactive T cells by treatment with dacarbazine, cisplatin, interferon‐alpha ± interleukin‐2 in patients with metastatic melanoma
  International Journal of Cancer, 1999
• Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
  Cancer Chemotherapy and Pharmacology, 1997
• The charing cross hospital experience with temozolomide in patients with gliomas
  European Journal Of Cancer, 1996
• Fotemustine in the Treatment of Brain Primary Tumors and Metastases
  Cancer Investigation, 1994
• Interferon-α and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials
  Cancer, 1993
• Metastatic pattern of malignant melanoma
  The American Journal of Surgery, 1978